{"id":"W2800064122","doi":"10.2147/bctt.s162841","title":"Progression-free survival/time to progression as a potential surrogate for overall survival in HR+, HER2&amp;ndash; metastatic breast cancer","year":2018,"lang":"en","type":"article","venue":"Breast Cancer Targets and Therapy","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"ca_institutions":"Novartis (Canada)","funders":"European Society for Medical Oncology","keywords":"Medicine; Internal medicine; Oncology; Progression-free survival; Breast cancer; Metastatic breast cancer; Surgical oncology; Univariate analysis; Chemotherapy; Cancer; Multivariate analysis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02404777,0.0007950921,0.003481793,0.002403375,0.0001839808,0.001273591,0.0007969072,0.0008883944,0.00196692],"category_scores_gemma":[0.04411259,0.000345875,0.009282644,0.003152501,0.0005901091,0.001042521,0.0006124574,0.001315524,0.0001358064],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001212967,"about_ca_system_score_gemma":0.001625147,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001339737,"about_ca_topic_score_gemma":0.003194961,"domain_scores_codex":[0.9826575,0.01203993,0.002799927,0.0009518252,0.001419742,0.0001310354],"domain_scores_gemma":[0.9462157,0.04456574,0.007579848,0.00059063,0.0008896653,0.000158399],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"observational","study_design_scores_codex":[0.01695535,0.0001249148,0.05194134,0.6122203,0.1753239,0.0002097431,0.0002597477,0.002827587,0.0006784112,0.002160587,0.001735445,0.1355626],"study_design_scores_gemma":[0.01121914,0.006877711,0.1068253,0.1390085,0.6974321,0.0009829333,0.0004349688,0.00637423,0.001635518,0.00666335,0.02238696,0.0001592071],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.02724884,0.9678075,0.002027793,0.0005060182,0.0001403405,0.0005353006,0.0009196984,0.00001339198,0.0008011259],"genre_scores_gemma":[0.7151746,0.2723533,0.006956469,0.0008347656,0.0003211593,0.002626878,0.00125496,0.00001968122,0.0004582005],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.02404777,"threshold_uncertainty_score":0.1271783,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01961974638594324,"score_gpt":0.3440960919603364,"score_spread":0.3244763455743931,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}